OM — Outset Medical, Inc.
Outset Medical, Inc. is a medical technology firm that specializes in developing hemodialysis systems. The company's primary product is the Tablo Hemodialysis System, a compact console designed to deliver dialysis treatment in various environments, including hospitals and patients' homes. This innovative system boasts integrated water purification, on-demand production of dialysate, and advanced software complete with connectivity features. Founded in 2003, the company initially operated under the name Home Dialysis Plus, Ltd. before rebranding to Outset Medical, Inc. in January 2015. Its corporate headquarters are located in San Jose, California.
Company profile
- Sector: Healthcare
- Industry: Medical - Devices
- Country: US
- Exchange: NASDAQ Global Select
- Employees: 354
- Website: https://www.outsetmedical.com
Latest SEC filings for OM
- SCHEDULE 13G/A — 2026-10-06
- 8-K — 2026-08-28
- SCHEDULE 13G — 2026-08-12
- SCHEDULE 13G/A — 2026-08-12
- 10-Q — 2026-08-06
- 8-K — 2026-08-06
- 8-K — 2026-06-17
- 8-K — 2026-06-05
- 8-K — 2026-05-29
- SCHEDULE 13G/A — 2026-05-18
Latest OM news
- — Here's Why You Should Retain DaVita Stock in Your Portfolio for Now (Zacks Investment Research)
- — Reasons to Retain Hims & Hers Stock in Your Portfolio for Now (Zacks Investment Research)
Educational tool only — not investment advice.